Staff Scientist, Bioinformatics, Thermo Fisher Scientific
BIOGRAPHY
AUG 16, 2018 8:00 AM PDT
Advancing precision immunotherapy through next-generation sequencing of T cell receptors: Part I
Speaker
Event Date & Time
DATE: August 16, 2018
TIME: 08:00AM PDT
TIME: 08:00AM PDT
Abstract
Immuno-Oncology Webinar Series (#2 of 3)
This webinar will review recent advancements in the application of next-generation sequencing of T cell receptor beta (TCRB) chain repertoires towards predictive and mechanistic biomarker discovery for cancer immunotherapy. Dr. Looney will focus on immunotherapy biomarker applications of a long-amplicon TCRB sequencing assay which provides coverage of the CDR1, 2 and 3 regions of the rearranged TCRB chain. He will highlight recent data from individuals receiving checkpoint blockade immunotherapy for cancer which suggest that long-amplicon TCRB repertoire sequencing of pre-treatment peripheral blood may be used to identify predictive biomarkers for immune-mediated adverse events and objective clinical response.
Learning Objectives:
- Understand current applications of T cell receptor sequencing to immunotherapy translational research.
- Describe the advantages of long-amplicon TCRB sequencing via Ion Torrent for immunotherapy biomarker discovery from peripheral blood.
Register for our 3 Part Series here:
- #2 - Advancing precision immunotherapy through next-generation sequencing of T cell receptors: Part I
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
AUG 16, 2018 8:00 AM PDT
Share
Advancing precision immunotherapy through next-generation sequencing of T cell receptors: Part I
Loading Comments...